Trading Signals: HALO Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Halozyme Therapeutics Inc)
| HALO latest price $38.8600 (0.18%) ($38.4300 - $39.8000) on Mon. Nov. 16, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.88% (three month average) | RSI | 80 | Latest Price | $38.8600(0.18%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | HALO advances 0.8% a day on average for past five trading days. | Weekly Trend | HALO advances 15.1% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support HALO advance at 0% a week (0% probability) IWO(51%) IBB(50%) IWM(48%) IWC(45%) ARKG(42%) | Factors Impacting HALO price | HALO will decline at least -1.44% in a week (0% probabilities). VIXM(-30%) VXX(-13%) UUP(-13%) EDOC(-8%) TLT(-0%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.44% (StdDev 2.88%) | Hourly BBV | -0.5 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $38.48(0.99%) | 10 Day Moving Average | $36.64(6.06%) | 20 Day Moving Average | $33.31(16.66%) | To recent high | 0% | To recent low | 51% | Market Cap | $5.311b | | | | Halozyme Therapeutics, Inc. is a biopharmaceutical company, which engages in research, development & commercialization of human enzymes and drug candidates. It focuses on novel oncology therapies that target the tumor microenvironment. Its products include PEGPH20, HTI-1511, PEG-ADA2, and HYLENEX recombinant. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA. |